https://www.investors.com/wp-content/uploads/2026/09/A1MAIN_vaccines_100226_gash.jpg

Is A Cancer Vaccine Coming? Moderna, Merck Boosted By The Buzz

Moderna (MRNA) and Merck (MRK) did the unthinkable in August in the never-ending battle against cancer. Study results showed their long-pursued cancer vaccine reduced the odds that surgically removed melanoma would return. Experts hailed the news as a "landmark win" that could add billions in sales and boost Moderna stock and shares of its biopharma partner.

12% Bond Yields Aren't A Myth — They're Up For Grabs Now

Nvidia Stock Regains 'Top Pick' Status At Morgan Stanley

How Much Monthly Income Do You Need To Retire Comfortably?

Tesla Delivered 486,532 Electric Vehicles In Q3, Beating Estimates. The Stock Is Rising.

Today's Spotlight

Get fresh trade ideas, market analysis and investing insights delivered daily for $20/year.

Learn More >

Uncover big winners earlier with the Blue Dot feature—here’s how it works.

Try It Today >

Navigate market volatility and stay on top of your trades with IBD Digital—try 2 months for $20.

Subscribe >

Investor's Business Daily - a Dow Jones affiliate

IBD, IBD Digital, IBD Live, IBD Weekly, Investor's Business Daily, Leaderboard, MarketDiem, MarketSurge and other marks are trademarks owned by Investor's Business Daily, LLC.

Sent to: dupa@niepodam.pl

Investor's Business Daily, LLC, PO Box 300, Princeton, NJ 08543-0300

Need help? Have feedback? Feel free to contact us

Terms of Use | Privacy Notice | Manage Subscriptions | Unsubscribe

ID: 7133